The next nanosonics or impedimed, page-3

In the October Presentation, the company says its rerate should be similar to IPD. That would value ACG at around $150m because ACG's target market is 2/3 the size of IPD's. Taking into consideration the time factor, I reckon at least one third of that (i.e. $50m m/c or 30c) should be achievable in the short-term.

Actually, $60m or 36c feels about right for where they're at. They already have sales. Just needs medicare rate decided and finalisation of Category 1. Not saying it will get to 36c tomorrow, but short-term seems reasonable.

It's also the highest percentage riser today, Motley Fool have mentioned it, and there's a conference call tomorrow, so plenty to keep interest going.